chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a female patient at an elementary school of kindergarten to fourth grade, who was vaccinated with a dose of varicella virus vaccine live . Subsequently, between 3/1/04 and 4/5/04, the patient developed breakthrough varicella. The patient had less than fifty pox and was afebrile. The Unspecified medical attention was sought. A product quality complaint was not involved. The reporter also mentioned other cases of breakthrough varicella at the same elementary school (WAES0404USA01117, 0404USA01259 through 0404USA01263 and 0404USA01265). Additional information is not available.
sick; Upper Respiratory Infection; bronchitis; Anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), UPPER RESPIRATORY TRACT INFECTION (Upper Respiratory Infection), BRONCHITIS (bronchitis) and ANXIETY (Anxiety) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced ILLNESS (sick), UPPER RESPIRATORY TRACT INFECTION (Upper Respiratory Infection), BRONCHITIS (bronchitis) and ANXIETY (Anxiety). At the time of the report, ILLNESS (sick), UPPER RESPIRATORY TRACT INFECTION (Upper Respiratory Infection), BRONCHITIS (bronchitis) and ANXIETY (Anxiety) outcome was unknown.            No concomitant medications were reported by reporter.  No treatment information provided.   This case was linked to MOD-2022-452712 (Patient Link).
FIEBRE VOMITOS SABOR METALICO EN LA BOCA  ESCALOFRIOS DOLOR DE CABEZA DOLOR MUSCULAR
No soreness or pain at the injection site. About 12 hours after the vaccine, I started feeling very cold and had a sort of disturbed night. The next day I did not want to do anything, it felt like I had the flu. I felt fatigued, like I had some pressure on me. My next night was more or less normal and the next day I felt more or less normal.  I started probably before the second dose feeling my left knee swelling. I also felt like a nerve pain, in on the left knee. The right one did not bother me at all. It is not just a knee pain it is like a nerve pain the knee and the upper calf. My knee feels inflated like a bike tire. My left knee is now much less mobile than my right knee. I did not see my doctor, just called his office and said I was concerned about a DVT so he suggested the ultrasound and later one physical therapy.  The PT helped me  a lot  in the beginning but then stopped getting any better and still does not feel right.
I woke up at 7AM having migraines, chills, nausea and severe migraine. Contacted PCP for prescription.
developed a severe rash on both thighs, both outer biceps, left and right torso; is extremely uncomfortable and painful; caused a severe lack of sleep; The rash is extremely itchy; has burning sensations; This is a spontaneous report from a contactable consumer or other non hcp. A 37-years-old male patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 06Jul2021 13:30 (Age at vaccination 37 years old) (Batch/Lot Number: EW0191) as DOSE 2, SINGLE for covid-19 immunisation.  Medical history included hypertension from an unknown date and unknown if ongoing Other medical history: High blood pressure. Concomitant medication included lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported.  Historical vaccine product COVID 19, brand Pfizer, lot number ER8736, lot unknown False, administration date 09Jun2021, at 01:30 PM, dose number 1, vaccine location Left arm for covid 19 immunisation. treatment with Steroid shot, Valtex, Prednisone, Bacatracin. Patient does not have covid prior vaccination nor covid tested post vaccination. on 07Jul2021 12:00 A Day after her second shot patient developed a severe rash on both thighs, both outer biceps, left and right torso. Patient have been to urgent care twice to receive medications for the rash. It is extremely uncomfortable and painful. It is almost at the second week now and has crippled her morale l and has caused a severe lack of sleep. It has also spread to her right hand. The rash is extremely itchy and has burning sensations. Therapeutic measures were taken as a result of developed a severe rash on both thighs, both outer biceps, left and right torso (rash), is extremely uncomfortable and painful (rash), caused a severe lack of sleep (sleep deficit), the rash is extremely itchy (rash pruritic), has burning sensations (burning sensation). Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
tremor, ataxia, fever, cranky;adm to hosp 4JUN;sx abated by 7JUN;temp nl;tremor/dysmetria;ataxic gait; better 7JUN;14JUN still unsteady on rising;
Patient report nausea, diarrhea "feeling ill" to point of needing to miss work. Started yesterday did not feel well enough to eat dinner and is still feeling ill this am. After dose # 2 had diarrhea resolving within 48hrs.
This spontaneous report was received from a registered nurse referring to a patient of unknown age. On 05-JAN-2016 the patient was vaccinated with a dose of improperly stored VAQTA (lot # L039659, exp date: 15-MAR-2017). The product was stored in temperature of 50.2 F degrees for 1 hour 10 minutes. The temperature excursion was recorded by a data logger. There was no previous temperature excursion. No adverse effects reported. This is one of several reports received from same source. Additional information has been requested.
6 hours post vaccination experienced the following symptoms: tachycardia, fever, chills, fatigue, joint pain, nausea, dizziness, and headache. These symptoms mostly resolved on their own after 24-36 hours. At approximately 48 hours post vaccination began experiencing chest pains described and still experienced occasional tachycardia, and after leaving work presented to the Emergency Room.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 5 (booster), single (Lot number: GJ3277), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 21Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 11Apr2021 as dose 2, single (Lot number: EW0151), in left arm, on 13Nov2021 as dose 3 (booster), single (Lot number: FD0809), in left arm and on 02May2022 as dose 4 (booster), single (Lot number: FJ4991), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Season allergies" (unspecified if ongoing), notes: Season allergies. The patient's concomitant medications were not reported. The patient was an endurance athlete. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Jan2023) Negative; (28Jan2023) Negative; (02Feb2023) Positive, notes: still tested Positive on 02Feb2023. Therapeutic measures were taken as a result of drug ineffective, COVID-19: the patient received Paxlovid from 22Jan2023 to 26Jan2023 for treatment of COVID-19. The patient tested negative on 27Jan2023 and 28Jan2023 and then original symptoms returned on 30Jan2023 (brain fog, fever, chills, sweating, headache, congestion, cough, achiness) plus one additional symptom, loss of smell and taste. Symptoms were miserable through 02Feb2023 when the patient started to improve (still tested positive on 02Feb2023).
Reporting nurse indicated several vaccinees have c/o pain on inject, arm soreness, heavy arms w/Engerix-B;
On September 1, 2022, I tested positive for COVID-19. I had a lot of head congestion, sneezing, coughing, fluids in my chest, joints hurt, and a fever of 101.6. I felt real tired. I contacted my doctor that morning when I tested positive. I had a virtual appointment and my doctor prescribe me PAXLOVID. I took that for five days. I tested positive everyday up until September 6, 2022, It came back negative that day.
it was rpt a pt exp a rash on leg, about 3-4 cm in diameter, raised warm & red 2days p/vax.
Information has been received concerning a 60 year old male patient who on an unknown date, was vaccinated with a dose of PNEUMOVAX 23, IM (dose, lot number not reported). On 12-FEB-2012, the patient experienced redness of the upper arm, pain and swelling. The patient was hospitalized and was still in the hospital. The patient was given antibiotics. At the time of the report the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Got the 2nd dose of Corona Vaccine Moderna at 12:45pm yesterday - at 6p, started to feel weak/dizzy - then this am on 2/22/21 at approx 6:30, pt had a syncopal episode with preceding dizziness, denies cp/fever.
syncope-recovered quickly when layed down c/o throat tightness-did not progress to allergic reaction
She got her vaccine, had headaches, fever, chills, shakes, shivers, nausea and diarrhea.  She has never recovered, had fever over a week, called the pediatrician and told her to drink a coke to coat her stomach, never got better, continued throwing up.  Went to the ER and hooked up to an IV for several hours, dehydrated and treated her.  She is still having dizziness, nauseous and not keeping anything down, was given another drip and then admitted for 3 days for severe dehydration.  Upon that admission they did a pregnancy test, to see if she had a ruptured ovarian cyst, took X-rays of her appendix and other tests.  After being treated for 3 days sent her home, felt a little better.  She then got sick again and has an appointment with a gastroenterologist.    She has not been to school since January do to this, she has lost her job.  She tried to go to school and has a plan for her to be home schooled.  She has missed out of 1/2 of her year of school so far.    She saw the gastroenterologist, put her on erythromycin, given Zofran for a while.  put her on Prilosec which did not work either.  She had an endoscopy and colonoscopy on 2/14/22 and did cancer screenings as well, scans lit up.  Th colonoscopy showed sevearl lesions around the colon and EGD showed lesions along the esophageal tract.  They tested her for Crohn's.  She was diagnosed with IBS.  She was then back in the ER vomiting blood and having diarrhea.  She had a motility test and is having motility problems, and her esophagus is not connected with the digestive tract.  She was diagnosed with gastroparesis.  She was put on a liquid medication as she can now not able to swallow pills.  She is now 17 years old, and she has an NG tube coming out of her nose and a stimulator to stimulate her stomach about 3 weeks ago.    The stimulator right now that she has is temporary and now being 17 they will not see her, and she has 2 choices to go to another state or to go 3 hours away, and has decided to that.  Mom has now taken off about 21 days of work due to her daughter's illness.  Next Friday she is scheduled for a permanent stimulator where she will have 5 years of relief, and will still be on medication to help her.  She is at a point that she cannot take the medication anymore as it can cause neurological issues as well.  She has also been in counseling due to the events, missing school and may not be able to take her tests.    She was healthy prior to her vaccines, never saw doctors due to the PCOS, but otherwise healthy.  Mother said she got the 3rd shot at 4:00 PM and woke up the next day not the same and continues with these symptoms.  She has had numerous COVID tests, and many tests.  She has had the nuclear scan to see how her digestive tract is working several times.
COVID-19 Vaccine EUA; 14-15 hours after injection, developed chills, low-grade fever (99.9F), muscle aches, malaise, restlessness (probably from fever). Symptoms lasted 24-30 hours after they started
This spontaneous report was received from a pharmacist via company representative regarding a male patient of unknown age. Patient's concurrent conditions included diabetes. Information on patient's medical history, concomitant medications and dug allergies were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose, units, anatomical location,route, lot# and expiry were not reported) for prophylaxis. On an unknown date, the patient developed redness (injection site erythema) and itching at the injection site (injection site pruritus) after receiving PNEUMOVAX 23.The patient had received treatment.The patient did not sought medical attention.The outcome of the events was recovered. Causality assessment was not provided. No Product Quality Complaint (PQC) was involved.
45 minutes after injection - developed bilat. chest pain and around to back. Short of breath. Took Benadryl 50mg PO and felt better in 5-10 min. Also had a lot of indigestion and belching.
The pt had a negative rubella titer. The pt sought unspecified medical attention. It was also noted the pt experienced product confusion on 1/5/01 with measles virus vax. Additional information has been requested.
Severe body aches (felt like I had been hit with a hammer all over my body with sharp stabbing pain), followed by lightheadedness and extreme nausea and vomiting from 12 hours after the shot until 24 hours after the shot.  Mild aches and fatigue continued after this point.
Information has been received from a registered nurse, for VARIVAX (Merck), a Pregnancy Registry product, concerning an 18 year old female patient without drug reactions. The patient's grandmother had heart problems. The patient's history of previous pregnancies and live births was not known. The patient who was pregnant was vaccinated with the second dose of 0.5 ml VARIVAX (Merck) (lot number H006951, expiration date unknown) subcutaneously on 24-SEP-2012. No other co-suspects were reported. There were no concomitant medication. The patient became pregnant with an LMP of 13-AUG-2012 and an EDD of 20-MAY-2013. Initial exposure to VARIVAX (Merck) was at 6 weeks. The patient was exposed to VARIVAX (Merck) during trimester 1. No treatment was given for adverse event. No laboratory diagnostics studies were performed. The patient was sought medical attention via office visit. Follow-up information was received. Patient details were updated. The vaccine was administered by a registered nurse in a public health clinic/hospital and the VARIVAX (Merck) was purchase with public funds. On 24-SEP-2012 the patient was vaccinated with VARIVAX (Merck) (lot # H006951, expiration date not reported) subcutaneously in the right arm. Concomitant vaccines included TDAP, Hepatitis A virus vaccine (unspecified) and MENACTRA given on 24-SEP-2012. Patient had not delivered and has had no prenatal care as of today (at the time of the report). She was suppose to have OD appointment at the time of this report but did not show. Patient was tested for varicella antibodies before vaccination with VZV containing vaccine. There was no local reaction at vaccination site. Follow-up information received. The lot number H006951. Follow up information has been received from the physician and the registered nurse. It was reported that the patient did not showed last appointment and they had not seen her since vaccine given. Additional information has been requested.
Right arm very tender to the touch from shoulder to finger tips. 01/24/2003 Pt has strai radial apparent and loss of ROM or strength. No redness or induration at injection site. Small 1cm bruise.
On March 8th received the J&J shots, March 9, 10th & 11th was extremely nauseous in the morning.  On the 12th had severe chest pains which I chalked up to a very bad case of heart burn.  On March 24th, while driving I had two major (what I thought at the time) was panic attacks...body started shaking, heart was beating like crazy, couldn't catch my breath, felt like I was going to pass out or die.  Had to pull over twice to calm myself down.  (From what I read this could be a sign of a blood clot but I am not a doctor.)  Had minor heart burn until April 5th....which ironically was the end of my 28 days until the vaccine fully kicked in.  Just reporting what happen.  I feel fine now.
patient stated a day or so after getting flu shot, she developed a rash with itching around injection site and also area on chest and back. patient has had many flu shots in past and has never had a reaction before. patient has upcoming appointment with her doctor if symptoms don't subside soon
Never got the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK Receipt Date: 27-May-2022 Reporter's Comments: The health care professional reported patient got first dose of shingrix in 2019 never got the 2nd dose. The patient was immunocompetent. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. The details were reported for 1st dose.  Additional Supportive Information: Till the time of reporting the patient did not received 2nd dose of shingrix which led to incomplete course of vaccination.
2nd dose received 14days after first dose.  It appears that the pt returned 2/26 instead of the scheduled 3/26.  First dose Moderna IM Left Deltoid, Lot 011M20A.  No adverse reaction. Pt stable and released from vaccination site.  Event reported on 6/30/21.
Information has been received from a physician concerning a 21 year old male who on an unspecified date was vaccinated intramuscularly with the first dose of GARDASIL (lot #: 668229/1569Z) (Expiration unknown). On the same day, concomitant therapy diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, meningococcal conj vaccine (unspecified) and "PPD" vaccine (unspecified). On an unspecified date, the patient promptly fainted and fell sideways. The patient hadn't receive another dose yet. The patient did not seek medical attention. No treatment was given. At the time of the report, the patient had recovered. Additional information has been requested.
On Thursday, 1/14/21 I found a large ?lump? under my collarbone on my left side. It was tender. Went to my PCP and she found further cervical, axillary, supraclavicular, and infraclavicular adenopathy (all on the left side)I had labwork,  X-ray, mammogram, and ultrasound on 1/15/21. Also, on 1/15/21 I started to have a lot of discomfort in my left shoulder. Everything came back good. On 1/16/21 I woke up and the area around my vaccination site was reddened, swollen, and itchy. This cleared up by 1/17/21. Used ice to assist. Today, 1/21/21, I still have a lot of discomfort and limited ROM in my left arm. The lymph node under my clavicle is still large and tender.
No adverse event; Administered vaccine that had been stored incorrectly; Administered vaccine that had been stored incorrectly; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that had been stored incorrectly), POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that had been stored incorrectly) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    In September 2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In September 2023, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that had been stored incorrectly) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that had been stored incorrectly). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that had been stored incorrectly), POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that had been stored incorrectly) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Administered vaccine that had been stored incorrectly) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that had been stored incorrectly).    No concomitant medications were reported.  It was reported that the reporter attended an event and an acquaintance (45-50 years) mentioned that he had received the COVID-19 2023-2024 formulation a few weeks ago. He reported no adverse events associated with the vaccine but stated that two days after receipt of the vaccine he got to know that the vaccine had been stored incorrectly and invited him to repeat the vaccination.   No treatment medications were provided.
wasn't able to take it until recently again and I don't know what's going to happen to me if I take it and it's been almost like 3 months."; Have vestibular issue and it agitated; This is a spontaneous report from a Pfizer sponsored program . A contactable consumer reported for self.   A female patient of an unspecified age, received second dose of BNT162B2 (Solution for injection, Batch/lot number: ER8736) via an unspecified route of administration, on an unknown date in May2021, as dose 2 single for Covid-19 immunization. Medical history included Have vestibular issue. Concomitant medications were not reported. The patient received second dose 2 and a half months after the first, she was Worried about the efficacy because waited longer than 21 days; Took the vaccine in May but she wasn't able to take it until recently. Have vestibular issue and it was agitated . The patient wanted to know if there will be some kind of Adverse reaction to that." The patient stated that I took the vaccine in May but I wasn't able to take it until recently again and I don't know what's going to happen to me if I take it and it's been almost like 3 months." The out-come of the events was unknown.
No adverse effect reported; temperature excursion / temperature 34.8 F; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information regarding their medical history, concurrent conditions nor concomitant therapies provided.  On 26-OCT-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # U007652, expiration date 14-APR-2023 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine was stored in a temperature of 34.8 degree Fahrenheit (F) for 192 hours. No previous temperature excursion occurred. No adverse effect was reported.  This is one of several reports from the same reporter. ; Sender's Comments:  US-009507513-2112USA000788: US-009507513-2112USA000785: US-009507513-2112USA000790: US-009507513-2112USA000791: US-009507513-2112USA000789: